|
|
|
Insider
Information: |
Sachdev Amit |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
71,325 |
|
Indirect Shares
|
7,447 |
|
|
Direct
Value |
$26,276,609 |
|
|
Indirect Value
|
$3,536,953 |
|
|
Total
Shares |
78,772 |
|
|
Total
Value |
$29,813,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-01-18 |
4 |
OE |
$18.93 |
$225,532 |
D/D |
11,914 |
51,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-02-23 |
4 |
OE |
$18.93 |
$451,064 |
D/D |
23,828 |
67,954 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-02-28 |
4 |
OE |
$18.93 |
$225,551 |
D/D |
11,915 |
56,041 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-03-03 |
4 |
OE |
$18.93 |
$180,422 |
D/D |
9,531 |
49,685 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-03-30 |
4 |
OE |
$18.93 |
$360,844 |
D/D |
19,062 |
60,170 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-05-07 |
4 |
OE |
$29.25 |
$1,645,313 |
D/D |
56,250 |
89,858 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-09-13 |
4 |
OE |
$29.25 |
$854,954 |
D/D |
28,281 |
59,389 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-09-14 |
4 |
OE |
$32.16 |
$306,517 |
D/D |
9,531 |
30,639 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-09-21 |
4 |
OE |
$32.16 |
$306,517 |
D/D |
9,531 |
30,639 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-05 |
4 |
OE |
$32.16 |
$2,041,329 |
D/D |
61,907 |
90,894 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-11 |
4 |
OE |
$33.28 |
$232,960 |
D/D |
7,000 |
35,987 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-12 |
4 |
OE |
$33.28 |
$1,256,235 |
D/D |
37,500 |
66,487 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-19 |
4 |
OE |
$33.28 |
$744,598 |
D/D |
22,250 |
51,237 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2014-06-24 |
4 |
OE |
$33.28 |
$1,420,998 |
D/D |
42,250 |
80,921 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2014-09-30 |
4 |
OE |
$33.28 |
$3,244,925 |
D/D |
86,000 |
124,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2014-10-28 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
50,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2014-11-28 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
90,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-01-09 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
90,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-03-18 |
4 |
OE |
$39.05 |
$508,748 |
D/D |
12,000 |
101,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-03-20 |
4 |
OE |
$45.11 |
$546,649 |
D/D |
12,000 |
101,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-03-29 |
4 |
OE |
$37.86 |
$3,576,273 |
D/D |
80,500 |
179,835 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-06-01 |
4 |
OE |
$51.75 |
$1,578,375 |
D/D |
30,500 |
129,835 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-07-19 |
4 |
OE |
$77.31 |
$1,546,200 |
D/D |
20,000 |
119,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-19 |
4 |
OE |
$77.31 |
$2,589,732 |
D/D |
32,422 |
71,585 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-22 |
4 |
OE |
$83.36 |
$1,146,200 |
D/D |
13,750 |
52,913 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|